Dries Reynders
Overview
Explore the profile of Dries Reynders including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
713
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Thomassen D, Roychoudhury S, Amdal C, Reynders D, Musoro J, Sauerbrei W, et al.
BMC Med Res Methodol
. 2025 Mar;
25(1):56.
PMID: 40025441
Introduction: As patient-reported outcomes (PROs) are increasingly used in the evaluation of medical treatments, it is important that PROs are carefully analyzed and interpreted. This may be challenging due to...
2.
Prytula A, Reynders D, Goetghebeur E, Krupka K, Bacchetta J, Kanzelmeyer N, et al.
Pediatr Nephrol
. 2025 Jan;
PMID: 39865159
Background: We investigated factors associated with post-transplant growth in pediatric kidney transplant (KTx) recipients with a focus on plasma bicarbonate (HCO3) and estimated the effect of alkali treatment on growth....
3.
Thomassen D, Roychoudhury S, Amdal C, Reynders D, Musoro J, Sauerbrei W, et al.
BMC Med Res Methodol
. 2024 Nov;
24(1):290.
PMID: 39580440
Background: Patient-reported outcomes (PROs) play an increasing role in the evaluation of oncology treatments. At the same time, single-arm trials are commonly included in regulatory approval submissions. Because of the...
4.
Ost P, Siva S, Brabrand S, Dirix P, Liefhooghe N, Otte F, et al.
Eur Urol Oncol
. 2023 Oct;
7(3):462-468.
PMID: 37821242
Background: Treatment recommendations for patients with limited nodal recurrences are lacking, and different locoregional treatment approaches are currently being used. Objective: The aim of this trial is to compare metastasis-directed...
5.
Spaas M, Sundahl N, Kruse V, Rottey S, De Maeseneer D, Duprez F, et al.
JAMA Oncol
. 2023 Jul;
9(9):1205-1213.
PMID: 37410476
Importance: Although immune checkpoint inhibitors (ICIs) targeting programmed cell death 1 (PD-1) and PD-1 ligand 1 have improved the outcome for many cancer types, the majority of patients fails to...
6.
Ceelen W, Sandra L, Van de Sande L, Graversen M, Mortensen M, Vermeulen A, et al.
EBioMedicine
. 2022 Jul;
82:104151.
PMID: 35843174
Background: Pressurized intraperitoneal aerosolized chemotherapy (PIPAC) is a novel method to treat patients with peritoneal metastases (PM). We aimed to study the tolerability, safety, pharmacokinetics, and tumour response of nanoparticle...
7.
Mubanga C, Van Damme I, Trevisan C, Schmidt V, Phiri I, Zulu G, et al.
Diagnostics (Basel)
. 2021 Nov;
11(11).
PMID: 34829468
The lack of cheap, easy-to-use, rapid diagnostic tests has led to the development of several rapid diagnostic tests for cysticercosis. The new prototype two-strip, point of care test (TS POC)...
8.
Mubanga C, Trevisan C, Van Damme I, Schmidt V, Phiri I, Zulu G, et al.
Diagnostics (Basel)
. 2021 Nov;
11(11).
PMID: 34829386
taeniosis diagnosis is challenging because current tests perform sub-optimally and/or are expensive, require sophisticated equipment, infrastructure and trained manpower, and therefore are not community deployable. A recently-developed, multi-strip, point-of-care test...
9.
Obermueller T, Hautekiet J, Busto M, Reynders D, Belgioia L, Cats A, et al.
Eur J Cancer
. 2021 Sep;
157:165-178.
PMID: 34517306
Background: High-risk human papillomavirus (hrHPV) types represent the aetiological agents in a major proportion of anal squamous cell carcinomas (ASCC). Several studies have suggested a prognostic relevance of HPV-related markers,...
10.
Spaas M, Sundahl N, Hulstaert E, Kruse V, Rottey S, De Maeseneer D, et al.
BMC Cancer
. 2021 May;
21(1):514.
PMID: 33962592
Background: While the introduction of checkpoint inhibitors (CPIs) as standard of care treatment for various tumor types has led to considerable improvements in clinical outcome, the majority of patients still...